Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Octreotide Acetate in Acromegaly
NCT00242541Phase 4Terminated
- Sponsor
- Novartis
- Start
- Mar 2003
- Primary completion
- Aug 2005
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of octreotide in acromegaly, sponsored by Novartis. Started Mar 2003; status: terminated.
02
Drugs
octreotide
03
Conditions
acromegaly
Beyond the preview
Go deeper on NCT00242541.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00242541.